IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Achillion Pharmaceuticals in

CUSIP: 00448Q20 | 3 institutional holders

Quarters

Q3 2016Q2 2015Q2 2013
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2016

Arrowstreet Capital, Limited Partnership668,185
0.0% of portfolio›$5.4K
StyleTurnoverLocationFiled
Arrowstreet Capital, Limited Partnership
668,185$5.4K0.0%GARPHighBoston, MA2016-11-14